Fluidigm

Fluidigm enables our customers to uncover meaningful insights into health and disease, effectively identify actionable markers to inform life decisions, and accelerate the development of more effective therapies. Fluidigm focuses on the most pressing needs in translational and clinical research, including cancer, immunology, and immunotherapy. Leveraging proprietary CyTOF® and microfluidic capabilities, we provide an unprecedented view of health and disease through an innovative combination of large-scale cytometry, tissue imaging, and genomic solutions. Researchers rely on our systems to discover critical disease pathways, identify valuable new molecular biomarkers, and deeply profile key cell populations at single-cell resolution. As a trusted partner to leading academic, government, pharmaceutical, biotechnology, and plant and animal research laboratories worldwide, we strive to improve the quality of life for all of us.